Sang-Hyon Kim

14PUBLICATIONS
106CO-AUTHORS
Behavioural epidemiologyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 09, 2025
Efficacy and safety of low-dose rosuvastatin/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis.

Seong-Hyeok Bak, Kyung-Ann Lee, Sung Soo Kim

|Jun 26, 2025
Comparing the Efficacy and Safety of Fexuprazan and Lansoprazole for the Prevention of Nonsteroidal Anti-inflammatory Drug-Induced Peptic Ulcer.

Seokchan Hong, Ji Hyeon Ju, Sang-Heon Lee

|Apr 01, 2024
Effect of recombinant human bone morphogenetic protein-2 and osteoprotegerin-Fc in MC3T3-E1 cells.

Sang-Hyon Kim, Hye-Jung Choi, Sang-Min Lee

|Apr 01, 2024
Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study.

Min Wook So, Sang-Hyon Kim, Dong Wook Kim

|Dec 21, 2023
GCSB-5 regulates inflammatory arthritis and pain by modulating the mitogen-activated protein kinase signaling pathway in a murine model of rheumatoid arthritis.

Jihye Bang, Gyeonghwa Kim, Soo Young Park

|Nov 22, 2023
Factors for achieving target serum uric acid levels after initiating urate-lowering therapy in patients with gout: results from the ULTRA registry.

Hyunsue Do, Hyo Jin Choi, Byoongyong Choi

Pageof 3

Frequent Collaborators

6 joint publications

Chang-Nam Son

3 joint publications

Ji-Min Kim

3 joint publications

Hyun-Sook Kim

3 joint publications

Won-Ki Baek